Independent Review Panel to Assess Criteria for Alternative Neurocognitive Tests Validation

The Office of Aerospace Medicine is developing alternative neurocognitive screening tests, partnering with three neurocognitive test developers to create derivative tests tailored to Federal Aviation Administration (FAA) requirements and supported by pilot normative data. However, the neuropsychology community of practice has expressed concerns about the need for revalidation of the derivative tests before clinical adoption. Therefore, an Independent Review Panel is required as soon as practical to evaluate the tests objectively and provide guidance on further development to ensure scientific validity, adherence to professional standards, and alignment with FAA requirements.